Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Azacitidine With Carboplatin and Paclitaxel for Suboptimal Newly Diagnosed Ovarian Cancer

NCT00842582 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.

NCT NCT00842582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Azacitidine With Carboplatin and Paclitaxel for Suboptimal Newly Diagnosed Ovarian Cancer
Lead sponsor
Loyola University
Phase
Phase 1
Overall status
Withdrawn
Start date
February 28, 2009
Completion date
March 31, 2011
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer